Market Analysis and Insights: Global Bipolar Disorder Market
The global Bipolar Disorder market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bipolar Disorder market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bipolar Disorder market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bipolar Disorder market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bipolar Disorder market.
Bipolar Disorder Breakdown Data by Type
Selective Serotonin Reuptake Inhibitor
Serotonin Norepinephrine Reuptake Inhibitors
Tricyclic Antidepressants
Monoamine Oxidase Inhibitors
Benzodiazepines
Beta Blockers
Bipolar Disorder Breakdown Data by Application
Mood Stabilizers
Anticonvulsants
Antipsychotic drugs
Antidepressant drugs
Antianxiety drugs
Based on regional and country-level analysis, the Bipolar Disorder market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Bipolar Disorder market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
Glaxo SmithKline (GSK)
Pfizer Inc.
Janssen Pharmaceuticals
Eli Lilly
Allergan Plc.
Novartis AG
AbbVie Inc.
Otsuka Holdings Ltd
AstraZeneca
The global Bipolar Disorder market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Bipolar Disorder market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Bipolar Disorder market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Bipolar Disorder market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Bipolar Disorder market.
Bipolar Disorder Breakdown Data by Type
Selective Serotonin Reuptake Inhibitor
Serotonin Norepinephrine Reuptake Inhibitors
Tricyclic Antidepressants
Monoamine Oxidase Inhibitors
Benzodiazepines
Beta Blockers
Bipolar Disorder Breakdown Data by Application
Mood Stabilizers
Anticonvulsants
Antipsychotic drugs
Antidepressant drugs
Antianxiety drugs
Based on regional and country-level analysis, the Bipolar Disorder market has been segmented as follows:
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of Middle East & Africa
In the competitive analysis section of the report, leading as well as prominent players of the global Bipolar Disorder market are broadly studied on the basis of key factors. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on price and revenue (global level) by player for the period 2015-2020.
The following players are covered in this report:
Glaxo SmithKline (GSK)
Pfizer Inc.
Janssen Pharmaceuticals
Eli Lilly
Allergan Plc.
Novartis AG
AbbVie Inc.
Otsuka Holdings Ltd
AstraZeneca
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bipolar Disorder Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Selective Serotonin Reuptake Inhibitor
1.2.3 Serotonin Norepinephrine Reuptake Inhibitors
1.2.4 Tricyclic Antidepressants
1.2.5 Monoamine Oxidase Inhibitors
1.2.6 Benzodiazepines
1.2.7 Beta Blockers
1.3 Market by Application
1.3.1 Global Bipolar Disorder Market Share by Application: 2020 VS 2026
1.3.2 Mood Stabilizers
1.3.3 Anticonvulsants
1.3.4 Antipsychotic drugs
1.3.5 Antidepressant drugs
1.3.6 Antianxiety drugs
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Bipolar Disorder Market Perspective (2015-2026)
2.2 Global Bipolar Disorder Growth Trends by Regions
2.2.1 Bipolar Disorder Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Bipolar Disorder Historic Market Share by Regions (2015-2020)
2.2.3 Bipolar Disorder Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bipolar Disorder Players by Market Size
3.1.1 Global Top Bipolar Disorder Players by Revenue (2015-2020)
3.1.2 Global Bipolar Disorder Revenue Market Share by Players (2015-2020)
3.2 Global Bipolar Disorder Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bipolar Disorder Revenue
3.4 Global Bipolar Disorder Market Concentration Ratio
3.4.1 Global Bipolar Disorder Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bipolar Disorder Revenue in 2019
3.5 Key Players Bipolar Disorder Area Served
3.6 Key Players Bipolar Disorder Product Solution and Service
3.7 Date of Enter into Bipolar Disorder Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bipolar Disorder Breakdown Data by Type (2015-2026)
4.1 Global Bipolar Disorder Historic Market Size by Type (2015-2020)
4.2 Global Bipolar Disorder Forecasted Market Size by Type (2021-2026)
5 Bipolar Disorder Breakdown Data by Application (2015-2026)
5.1 Global Bipolar Disorder Historic Market Size by Application (2015-2020)
5.2 Global Bipolar Disorder Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Bipolar Disorder Market Size (2015-2026)
6.2 North America Bipolar Disorder Market Size by Type (2015-2020)
6.3 North America Bipolar Disorder Market Size by Application (2015-2020)
6.4 North America Bipolar Disorder Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Bipolar Disorder Market Size (2015-2026)
7.2 Europe Bipolar Disorder Market Size by Type (2015-2020)
7.3 Europe Bipolar Disorder Market Size by Application (2015-2020)
7.4 Europe Bipolar Disorder Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Bipolar Disorder Market Size (2015-2026)
8.2 China Bipolar Disorder Market Size by Type (2015-2020)
8.3 China Bipolar Disorder Market Size by Application (2015-2020)
8.4 China Bipolar Disorder Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Bipolar Disorder Market Size (2015-2026)
9.2 Japan Bipolar Disorder Market Size by Type (2015-2020)
9.3 Japan Bipolar Disorder Market Size by Application (2015-2020)
9.4 Japan Bipolar Disorder Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Bipolar Disorder Market Size (2015-2026)
10.2 Southeast Asia Bipolar Disorder Market Size by Type (2015-2020)
10.3 Southeast Asia Bipolar Disorder Market Size by Application (2015-2020)
10.4 Southeast Asia Bipolar Disorder Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Glaxo SmithKline (GSK)
11.1.1 Glaxo SmithKline (GSK) Company Details
11.1.2 Glaxo SmithKline (GSK) Business Overview
11.1.3 Glaxo SmithKline (GSK) Bipolar Disorder Introduction
11.1.4 Glaxo SmithKline (GSK) Revenue in Bipolar Disorder Business (2015-2020))
11.1.5 Glaxo SmithKline (GSK) Recent Development
11.2 Pfizer Inc.
11.2.1 Pfizer Inc. Company Details
11.2.2 Pfizer Inc. Business Overview
11.2.3 Pfizer Inc. Bipolar Disorder Introduction
11.2.4 Pfizer Inc. Revenue in Bipolar Disorder Business (2015-2020)
11.2.5 Pfizer Inc. Recent Development
11.3 Janssen Pharmaceuticals
11.3.1 Janssen Pharmaceuticals Company Details
11.3.2 Janssen Pharmaceuticals Business Overview
11.3.3 Janssen Pharmaceuticals Bipolar Disorder Introduction
11.3.4 Janssen Pharmaceuticals Revenue in Bipolar Disorder Business (2015-2020)
11.3.5 Janssen Pharmaceuticals Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Bipolar Disorder Introduction
11.4.4 Eli Lilly Revenue in Bipolar Disorder Business (2015-2020)
11.4.5 Eli Lilly Recent Development
11.5 Allergan Plc.
11.5.1 Allergan Plc. Company Details
11.5.2 Allergan Plc. Business Overview
11.5.3 Allergan Plc. Bipolar Disorder Introduction
11.5.4 Allergan Plc. Revenue in Bipolar Disorder Business (2015-2020)
11.5.5 Allergan Plc. Recent Development
11.6 Novartis AG
11.6.1 Novartis AG Company Details
11.6.2 Novartis AG Business Overview
11.6.3 Novartis AG Bipolar Disorder Introduction
11.6.4 Novartis AG Revenue in Bipolar Disorder Business (2015-2020)
11.6.5 Novartis AG Recent Development
11.7 AbbVie Inc.
11.7.1 AbbVie Inc. Company Details
11.7.2 AbbVie Inc. Business Overview
11.7.3 AbbVie Inc. Bipolar Disorder Introduction
11.7.4 AbbVie Inc. Revenue in Bipolar Disorder Business (2015-2020)
11.7.5 AbbVie Inc. Recent Development
11.8 Otsuka Holdings Ltd
11.8.1 Otsuka Holdings Ltd Company Details
11.8.2 Otsuka Holdings Ltd Business Overview
11.8.3 Otsuka Holdings Ltd Bipolar Disorder Introduction
11.8.4 Otsuka Holdings Ltd Revenue in Bipolar Disorder Business (2015-2020)
11.8.5 Otsuka Holdings Ltd Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Bipolar Disorder Introduction
11.9.4 AstraZeneca Revenue in Bipolar Disorder Business (2015-2020)
11.9.5 AstraZeneca Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Bipolar Disorder Market Size Growth Rate by Type: 2020 VS 2026
1.2.2 Selective Serotonin Reuptake Inhibitor
1.2.3 Serotonin Norepinephrine Reuptake Inhibitors
1.2.4 Tricyclic Antidepressants
1.2.5 Monoamine Oxidase Inhibitors
1.2.6 Benzodiazepines
1.2.7 Beta Blockers
1.3 Market by Application
1.3.1 Global Bipolar Disorder Market Share by Application: 2020 VS 2026
1.3.2 Mood Stabilizers
1.3.3 Anticonvulsants
1.3.4 Antipsychotic drugs
1.3.5 Antidepressant drugs
1.3.6 Antianxiety drugs
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Bipolar Disorder Market Perspective (2015-2026)
2.2 Global Bipolar Disorder Growth Trends by Regions
2.2.1 Bipolar Disorder Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Bipolar Disorder Historic Market Share by Regions (2015-2020)
2.2.3 Bipolar Disorder Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Bipolar Disorder Players by Market Size
3.1.1 Global Top Bipolar Disorder Players by Revenue (2015-2020)
3.1.2 Global Bipolar Disorder Revenue Market Share by Players (2015-2020)
3.2 Global Bipolar Disorder Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Bipolar Disorder Revenue
3.4 Global Bipolar Disorder Market Concentration Ratio
3.4.1 Global Bipolar Disorder Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Bipolar Disorder Revenue in 2019
3.5 Key Players Bipolar Disorder Area Served
3.6 Key Players Bipolar Disorder Product Solution and Service
3.7 Date of Enter into Bipolar Disorder Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Bipolar Disorder Breakdown Data by Type (2015-2026)
4.1 Global Bipolar Disorder Historic Market Size by Type (2015-2020)
4.2 Global Bipolar Disorder Forecasted Market Size by Type (2021-2026)
5 Bipolar Disorder Breakdown Data by Application (2015-2026)
5.1 Global Bipolar Disorder Historic Market Size by Application (2015-2020)
5.2 Global Bipolar Disorder Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Bipolar Disorder Market Size (2015-2026)
6.2 North America Bipolar Disorder Market Size by Type (2015-2020)
6.3 North America Bipolar Disorder Market Size by Application (2015-2020)
6.4 North America Bipolar Disorder Market Size by Country (2015-2020)
6.4.1 United States
6.4.2 Canada
7 Europe
7.1 Europe Bipolar Disorder Market Size (2015-2026)
7.2 Europe Bipolar Disorder Market Size by Type (2015-2020)
7.3 Europe Bipolar Disorder Market Size by Application (2015-2020)
7.4 Europe Bipolar Disorder Market Size by Country (2015-2020)
7.4.1 Germany
7.4.2 France
7.4.3 U.K.
7.4.4 Italy
7.4.5 Russia
7.4.6 Nordic
7.4.7 Rest of Europe
8 China
8.1 China Bipolar Disorder Market Size (2015-2026)
8.2 China Bipolar Disorder Market Size by Type (2015-2020)
8.3 China Bipolar Disorder Market Size by Application (2015-2020)
8.4 China Bipolar Disorder Market Size by Region (2015-2020)
8.4.1 China
8.4.2 Japan
8.4.3 South Korea
8.4.4 Southeast Asia
8.4.5 India
8.4.6 Australia
8.4.7 Rest of Asia-Pacific
9 Japan
9.1 Japan Bipolar Disorder Market Size (2015-2026)
9.2 Japan Bipolar Disorder Market Size by Type (2015-2020)
9.3 Japan Bipolar Disorder Market Size by Application (2015-2020)
9.4 Japan Bipolar Disorder Market Size by Country (2015-2020)
9.4.1 Mexico
9.4.2 Brazil
10 Southeast Asia
10.1 Southeast Asia Bipolar Disorder Market Size (2015-2026)
10.2 Southeast Asia Bipolar Disorder Market Size by Type (2015-2020)
10.3 Southeast Asia Bipolar Disorder Market Size by Application (2015-2020)
10.4 Southeast Asia Bipolar Disorder Market Size by Country (2015-2020)
10.4.1 Turkey
10.4.2 Saudi Arabia
10.4.3 UAE
10.4.4 Rest of Middle East & Africa
11 Key Players Profiles
11.1 Glaxo SmithKline (GSK)
11.1.1 Glaxo SmithKline (GSK) Company Details
11.1.2 Glaxo SmithKline (GSK) Business Overview
11.1.3 Glaxo SmithKline (GSK) Bipolar Disorder Introduction
11.1.4 Glaxo SmithKline (GSK) Revenue in Bipolar Disorder Business (2015-2020))
11.1.5 Glaxo SmithKline (GSK) Recent Development
11.2 Pfizer Inc.
11.2.1 Pfizer Inc. Company Details
11.2.2 Pfizer Inc. Business Overview
11.2.3 Pfizer Inc. Bipolar Disorder Introduction
11.2.4 Pfizer Inc. Revenue in Bipolar Disorder Business (2015-2020)
11.2.5 Pfizer Inc. Recent Development
11.3 Janssen Pharmaceuticals
11.3.1 Janssen Pharmaceuticals Company Details
11.3.2 Janssen Pharmaceuticals Business Overview
11.3.3 Janssen Pharmaceuticals Bipolar Disorder Introduction
11.3.4 Janssen Pharmaceuticals Revenue in Bipolar Disorder Business (2015-2020)
11.3.5 Janssen Pharmaceuticals Recent Development
11.4 Eli Lilly
11.4.1 Eli Lilly Company Details
11.4.2 Eli Lilly Business Overview
11.4.3 Eli Lilly Bipolar Disorder Introduction
11.4.4 Eli Lilly Revenue in Bipolar Disorder Business (2015-2020)
11.4.5 Eli Lilly Recent Development
11.5 Allergan Plc.
11.5.1 Allergan Plc. Company Details
11.5.2 Allergan Plc. Business Overview
11.5.3 Allergan Plc. Bipolar Disorder Introduction
11.5.4 Allergan Plc. Revenue in Bipolar Disorder Business (2015-2020)
11.5.5 Allergan Plc. Recent Development
11.6 Novartis AG
11.6.1 Novartis AG Company Details
11.6.2 Novartis AG Business Overview
11.6.3 Novartis AG Bipolar Disorder Introduction
11.6.4 Novartis AG Revenue in Bipolar Disorder Business (2015-2020)
11.6.5 Novartis AG Recent Development
11.7 AbbVie Inc.
11.7.1 AbbVie Inc. Company Details
11.7.2 AbbVie Inc. Business Overview
11.7.3 AbbVie Inc. Bipolar Disorder Introduction
11.7.4 AbbVie Inc. Revenue in Bipolar Disorder Business (2015-2020)
11.7.5 AbbVie Inc. Recent Development
11.8 Otsuka Holdings Ltd
11.8.1 Otsuka Holdings Ltd Company Details
11.8.2 Otsuka Holdings Ltd Business Overview
11.8.3 Otsuka Holdings Ltd Bipolar Disorder Introduction
11.8.4 Otsuka Holdings Ltd Revenue in Bipolar Disorder Business (2015-2020)
11.8.5 Otsuka Holdings Ltd Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Bipolar Disorder Introduction
11.9.4 AstraZeneca Revenue in Bipolar Disorder Business (2015-2020)
11.9.5 AstraZeneca Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
